Abstract

Carvedilol 0.625-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2011 - Volume 15, Number 5

Page(s): 418

Download in electronic PDF format for $75
  • Carvedilol 0.625-mg/mL Oral Liquid Page 1

Abstract

A formulation for preparing Carvedilol 0.625-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • carvedilol
  • nonselective beta blocker
  • selective alpha-1 blocker
  • hypertension
  • high blood pressure
  • congestive heart failure

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2011
Pg. 418
Carvedilol 0.625-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2006
Pg. 220
Carvedilol 1.25-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2010
Pg. 423
Carvedilol 1-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 145
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 194-197
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
Sep/Oct 2009
Pg. 367-371
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Author(s): Williams LaVonn A, Riley Kari
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 333
Metoprolol Tartrate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 503
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 421
Metoprolol Tartrate 1.25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2011
Pg. 458-463
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Author(s): Zur Eyal
Jul/Aug 2016
Pg. 328-332
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Sep/Oct 2022
Pg. 364-368
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Author(s): Riepl Mike
Mar/Apr 2010
Pg. 108-111
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Author(s): Bramwell Bethany L
Jul/Aug 2006
Pg. 302
Lisinopril 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 504
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Author(s): Allen Loyd V Jr
May/Jun 2006
Pg. 227
Quinapril 1-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2018
Pg. 516-526
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4
Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Mar/Apr 2024
Pg. 129
Addendum to Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine A New Therapeutic Modality
Author(s):